D

DRUG5 trials

Sponsors

GlaxoSmithKline, Heidelberg University, Skaraborg Hospital, Imperial Brands PLC, Société des Produits Nestlé (SPN)

Conditions

Bacterial VaginosesHealthyHealthy VolunteersInfant and Young Child FeedingMultiple Sclerosis, Relapsing-RemittingVertebral Bony Metastases

Phase 1

Healthy Volunteer Pilot Study Using 3 Types of Modified Release Formulations of Firategrast to Investigate How Quickly Absorption From the Digestive System Takes Place.

CompletedNCT01424462

GlaxoSmithKlineMultiple Sclerosis, Relapsing-Remitting

Start: 2010-04-19End: 2010-07-06Updated: 2017-06-20

Phase 2

Intensity-modulated Radiotherapy With Integrated-boost in Patients With Spinal Bone Metastases

Heidelberg UniversityVertebral Bony Metastases

Start: 2016-09-30End: 2018-02-28Target: 120Updated: 2016-07-14

Unknown Phase

Treatment of BV With Donaxyl and a Molecular Test of Cure

CompletedNCT04057482

Skaraborg HospitalBacterial Vaginoses

Start: 2015-05-31End: 2018-04-30Updated: 2019-08-15

A Randomised, Cross-over, Relative Bioavailability Study of Nicotine Delivery and Nicotine Extraction From Oral Products

CompletedNCT04891406

Imperial Brands PLCHealthy Volunteers

Start: 2020-07-01End: 2021-01-20Updated: 2023-10-13

Effects of Staged Adapted Inclusions in Infant Cereals on Oral-motors Patterns of 6-24 Month-old Children

RecruitingNCT07318506

Société des Produits Nestlé (SPN)Healthy, Infant and Young Child Feeding

Start: 2025-11-05End: 2026-05-31Target: 153Updated: 2026-01-06

Related Papers

A randomised, open-label, cross-over clinical study to evaluate the pharmacokinetic, pharmacodynamic and safety and tolerability profiles of tobacco-free oral nicotine pouches relative to cigarettes.

2022-06-2323 citations

Intensity-modulated radiotherapy with integrated-boost in patients with bone metastasis of the spine: study protocol for a randomized controlled trial.

2018-01-229 citations